Dietary α-linolenic acid diminishes experimental atherogenesis and restricts T cell-driven inflammation

European Heart Journal

Volumn 32, Issue 20, 2011, Pages 2573-2584

  Winnik, Stephan ^a,b   Lohmann, Christine ^a,b   Richter, Eva K ^c   Schäfer, Nicola ^a,b   Song, Wen Liang ^d   Leiber, Florian ^c   Mocharla, Pavani ^a,b   Hofmann, Janin ^e   Klingenberg, Roland ^a,b   Borén, Jan ^f   Becher, Burkhard ^a,e   Fitzgerald, Garret A ^d   Lúscher, Thomas F ^a,b   Matter, Christian M ^a,b   Beer, Jürg H ^g,h  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c ETH ZURICH   (Switzerland)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^f UNIVERSITY OF GOTHENBURG   (Sweden)

^g UNIVERSITY OF BERN   (Switzerland)

^h Kantonsspital Baden   (Switzerland)

Author keywords

Linolenic acid; Atherosclerosis; Inflammation; Polyunsaturated fatty acids

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; GAMMA INTERFERON; ICOSAPENTAENOIC ACID; INTERLEUKIN 4; ISOPROSTANE; LINOLENIC ACID; PROSTAGLANDIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CD3+ T LYMPHOCYTE; CHOLESTEROL DIET; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIETARY INTAKE; DRUG BIOAVAILABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY ACID METABOLISM; GAS CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; LINSEED; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; URINALYSIS;

ALPHA-LINOLENIC ACID; ANIMALS; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; T-LYMPHOCYTES;

EID: 80051978142     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq501     Document Type: Article

References (51)

1. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-874. (Pubitemid 36019640)
2. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004;364:937-952. (Pubitemid 39208455)
3. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002;346:1113-1118. (Pubitemid 34984601)
4. Albert CM, Hennekens CH, O'Donnell CJ, Ajani UA, Carey VJ, Willett WC, Ruskin JN, Manson JE. Fish consumption and risk of sudden cardiac death. JAMA 1998;279:23-28. (Pubitemid 28070546)
5. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med 1995;332:977-982.
6. Albert CM, Oh K, Whang W, Manson JE, Chae CU, Stampfer MJ, Willett WC, Hu FB. Dietary alpha-linolenic acid intake and risk of sudden cardiac death and coronary heart disease. Circulation 2005;112:3232-3238. (Pubitemid 43739367)
7. Bays HE, Tighe AP, Sadovsky R, Davidson MH. Prescription omega-3 fatty acids and their lipid effects: Physiologic mechanisms of action and clinical implications. Expert Rev Cardiovasc Ther 2008;6:391-409.
8. Knapp HR, Reilly IA, Alessandrini P, FitzGerald GA. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N Engl J Med 1986;314:937-942. (Pubitemid 16129827)
9. Knapp HR, FitzGerald GA. The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supplements in essential hypertension. N Engl J Med 1989;320:1037-1043. (Pubitemid 19105747)
10. Calder PC. Effects of fatty acids and dietary lipids on cells of the immune system. Proc Nutr Soc 1996;55:127-150. (Pubitemid 126795328)
11. Hughes DA, Southon S, Pinder AC. (n-3) Polyunsaturated fatty acids modulate the expression of functionally associated molecules on human monocytes in vitro. J Nutr 1996;126:603-610. (Pubitemid 26081168)
12. Harris WS. International recommendations for consumption of long-chain omega-3 fatty acids. J Cardiovasc Med (Hagerstown) 2007;8 Suppl 1:S50-S52. (Pubitemid 47429084)
13. Campos H, Baylin A, Willett WC. Alpha-linolenic acid and risk of nonfatal acute myocardial infarction. Circulation 2008;118:339-345.
14. Harris WS. Alpha-linolenic acid: A gift from the land? Circulation 2005;111: 2872-2874. (Pubitemid 40814178)
15. Harper CR, Edwards MJ, DeFilippis AP, Jacobson TA. Flaxseed oil increases the plasma concentrations of cardioprotective (n-3) fatty acids in humans. J Nutr 2006;136:83-87. (Pubitemid 43156489)
16. Gerster H. Can adults adequately convert alpha-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)? Int J Vitam Nutr Res 1998;68:159-173. (Pubitemid 28259765)
17. Brenna JT, Salem N Jr., Sinclair AJ, Cunnane SC. Alpha-linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 2009;80:85-91.
18. Burdge GC, Calder PC. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 2005;45: 581-597. (Pubitemid 41511883)
19. Djousse L, Arnett DK, Carr JJ, Eckfeldt JH, Hopkins PN, Province MA, Ellison RC. Dietary linolenic acid is inversely associated with calcified atherosclerotic plaque in the coronary arteries: The National Heart, Lung, and Blood Institute Family Heart Study. Circulation 2005;111:2921-2926. (Pubitemid 40814184)
20. Mayer K, Meyer S, Reinholz-Muhly M, Maus U, Merfels M, Lohmeyer J, Grimminger F, Seeger W. Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans. J Immunol 2003;171:4837-4843. (Pubitemid 37310605)
21. Tull SP, Yates CM, Maskrey BH, O'Donnell VB, Madden J, Grimble RF, Calder PC, Nash GB, Rainger GE. Omega-3 fatty acids and inflammation: Novel interactions reveal a new step in neutrophil recruitment. PLoS Biol 2009;7:e1000177.
22. Ricci R, Sumara G, Sumara I, Rozenberg I, Kurrer M, Akhmedov A, Hersberger M, Eriksson U, Eberli FR, Becher B, Boren J, Chen M, Cybulsky MI, Moore KJ, Freeman MW, Wagner EF, Matter CM, Luscher TF. Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. Science 2004;306:1558-1561. (Pubitemid 39564952)
23. von Lukowicz T, Hassa PO, Lohmann C, Boren J, Braunersreuther V, Mach F, Odermatt B, Gersbach M, Camici GG, Stähli BE, Tanner FC, Hottiger MO, Luscher TF, Matter CM. PARP1 is required for adhesion molecule expression in atherogenesis. Cardiovasc Res 2008;78:158-166. (Pubitemid 351430953)
24. Osto E, Matter CM, Kouroedov A, Malinski T, Bachschmid M, Camici GG, Kilic U, Stallmach T, Boren J, Iliceto S, Luscher TF, Cosentino F. c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress. Circulation 2008;118:2073-2080.
25. Stein S, Schafer N, Breitenstein A, Besler C, Winnik S, Lohmann C, Heinrich K, Brokopp CE, Handschin C, Landmesser U, Tanner FC, Luscher TF, Matter CM. SIRT1 reduces endothelial activation without affecting vascular function in ApoE2/2 mice. Aging (Albany NY) 2010;2:353-360.
26. Hauswirth CB, Scheeder MR, Beer JH. High omega-3 fatty acid content in alpine cheese: The basis for an alpine paradox. Circulation 2004;109:103-107. (Pubitemid 38056029)
27. Song WL, Lawson JA,Wang M, Zou H, FitzGerald GA. Noninvasive assessment of the role of cyclooxygenases in cardiovascular health: A detailed HPLC/MS/MS method. Methods Enzymol 2007;433:51-72.
28. Song WL, Paschos G, Fries S, Reilly MP, Yu Y, Rokach J, Chang CT, Patel P, Lawson JA, Fitzgerald GA. Novel eicosapentaenoic acid-derived F3-isoprostanes as biomarkers of lipid peroxidation. J Biol Chem 2009;284:23636-23643.
29. Song WL, Wang M, Ricciotti E, Fries S, Yu Y, Grosser T, Reilly M, Lawson JA, FitzGerald GA. Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans. J Biol Chem 2008;283:1179-1188.
30. Faul F, Erdfelder E, Lang AG, Buchner A. Gz.ast;Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175-191.
31. FitzGerald GA, Pedersen AK, Patrono C. Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. Circulation 1983;67:1174-1177. (Pubitemid 13105335)
32. Calder PC, Yaqoob P, Thies F, Wallace FA, Miles EA. Fatty acids and lymphocyte functions. Br J Nutr 2002;87(Suppl. 1):S31-S48. (Pubitemid 34134102)
33. Galli C, Calder PC. Effects of fat and fatty acid intake on inflammatory and immune responses: A critical review. Ann Nutr Metab 2009;55:123-139.
34. Russo GL. Dietary n-6 and n-3 polyunsaturated fatty acids: From biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol 2009;77: 937-946.
35. Harris WS, Poston WC, Haddock CK. Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 2007;193:1-10. (Pubitemid 46776717)
36. Griffin BA. How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study. Curr Opin Lipidol 2008;19:57-62.
37. Dupasquier CM, Dibrov E, Kneesh AL, Cheung PK, Lee KG, Alexander HK, Yeganeh BK, Moghadasian MH, Pierce GN. Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and antiinflammatory actions. Am J Physiol Heart Circ Physiol 2007;293:H2394-H2402. (Pubitemid 47605886)
38. Hansson GK, Libby P. The immune response in atherosclerosis: A double-edged sword. Nat Rev Immunol 2006;6:508-519. (Pubitemid 43980523)
39. Methe H, Brunner S, Wiegand D, Nabauer M, Koglin J, Edelman ER. Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes. J Am Coll Cardiol 2005;45:1939-1945. (Pubitemid 40814112)
40. Niinisalo P, Oksala N, Levula M, Pelto-Huikko M, Jarvinen O, Salenius JP, Kytomaki L, Soini JT, Kahonen M, Laaksonen R, Hurme M, Lehtimaki T. Activation of indoleamine 2,3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere vascular study. Ann Med 2010;42:55-63.
41. Kang JX, Wang J, Wu L, Kang ZB. Transgenic mice: Fat-1 mice convert n-6 to n-3 fatty acids. Nature 2004;427:504. (Pubitemid 38209102)
42. Pellizzon MA, Billheimer JT, Bloedon LT, Szapary PO, Rader DJ. Flaxseed reduces plasma cholesterol levels in hypercholesterolemic mouse models. J Am Coll Nutr 2007;26:66-75. (Pubitemid 46411398)
43. Islam SA, Thomas SY, Hess C, Medoff BD, Means TK, Brander C, Lilly CM, Tager AM, Luster AD. The leukotriene B4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans. Blood 2006;107:444-453. (Pubitemid 43076363)
44. Back M, Sultan A, Ovchinnikova O, Hansson GK. 5-Lipoxygenase-activating protein: A potential link between innate and adaptive immunity in atherosclerosis and adipose tissue inflammation. Circ Res 2007;100:946-949. (Pubitemid 46598919)
45. Wada M, DeLong CJ, Hong YH, Rieke CJ, Song I, Sidhu RS, Yuan C, Warnock M, Schmaier AH, Yokoyama C, Smyth EM, Wilson SJ, FitzGerald GA, Garavito RM, Sui de X, Regan JW, Smith WL. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J Biol Chem 2007;282:22254-22266. (Pubitemid 47267340)
46. Audoly LP, Rocca B, Fabre JE, Koller BH, Thomas D, Loeb AL, Coffman TM, FitzGerald GA. Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo. Circulation 2000;101:2833-2840. (Pubitemid 30396015)
47. Kobayashi T, Tahara Y, Matsumoto M, Iguchi M, Sano H, Murayama T, Arai H, Oida H, Yurugi-Kobayashi T, Yamashita JK, Katagiri H, Majima M, Yokode M, Kita T, Narumiya S. Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice. J Clin Invest 2004;114:784-794. (Pubitemid 39578737)
48. Cayatte AJ, Du Y, Oliver-Krasinski J, Lavielle G, Verbeuren TJ, Cohen RA. The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice: Evidence that eicosanoids other than thromboxane contribute to atherosclerosis. Arterioscler Thromb Vasc Biol 2000;20:1724-1728. (Pubitemid 30470586)
49. Adkins Y, Kelley DS. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem 2010;21:781-792.
50. Oh da Y, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM, Olefsky JM. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010;142:687-698.
51. Kromhout D, Giltay EJ, Geleijnse JM, for the Alpha Omega Trial Group. n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 2010; 363:2015-2026.